Palatin Technologies (OTCMKTS:PTNT) Shares Pass Above 200 Day Moving Average – Should You Sell?

Palatin Technologies, Inc. (OTCMKTS:PTNT) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $15.61 and traded as high as $24.93. Palatin Technologies shares last traded at $24.93, with a volume of 62 shares traded.

Palatin Technologies Stock Up 0.3%

The stock’s 50-day moving average price is $25.86 and its 200-day moving average price is $15.75. The company has a market capitalization of $996,400.00, a price-to-earnings ratio of -16.07 and a beta of -1.33.

About Palatin Technologies

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.